Cargando…
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome
Neurogenesis impairment is considered a major determinant of the intellectual disability that characterizes Down syndrome (DS), a genetic condition caused by triplication of chromosome 21. Previous evidence obtained in the Ts65Dn mouse model of DS showed that the triplicated gene APP (amyloid precur...
Autores principales: | Stagni, Fiorenza, Raspanti, Alessandra, Giacomini, Andrea, Guidi, Sandra, Emili, Marco, Ciani, Elisabetta, Giuliani, Alessandro, Bighinati, Andrea, Calzà, Laura, Magistretti, Jacopo, Bartesaghi, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439029/ https://www.ncbi.nlm.nih.gov/pubmed/28359846 http://dx.doi.org/10.1016/j.nbd.2017.03.012 |
Ejemplares similares
-
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome
por: Giacomini, Andrea, et al.
Publicado: (2015) -
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome
por: Stagni, Fiorenza, et al.
Publicado: (2013) -
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse
por: Giacomini, Andrea, et al.
Publicado: (2019) -
Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone
por: Valenti, Daniela, et al.
Publicado: (2021) -
Timing of therapies for Down syndrome: the sooner, the better
por: Stagni, Fiorenza, et al.
Publicado: (2015)